Apatone is a proprietary solution that combines vitamin K3 and vitamin C. Vitamin C is an active antioxidant that has been found to prevent the induction of tumors in clinical experiments, while vitamin K3 alone was found to present antitumor activity. Apatone combines vitamin C and vitamin K3 in a 100:1 ratio. Studies found that the two vitamins may work synergistically to inhibit the growth of cancer cells and induce cell death via apoptosis.

Initial clinical research suggests that Apatone may work as an alternative cancer treatment by reducing compounds in tumors that contribute to energy production and provide protection against chemotherapy. This essentially allows for precise targeting of tumor cells without harming surrounding healthy tissue, containing normal cells. A standard therapy, such as chemotherapy or radiation, may eradicate cancer cells. However, any healthy cells and normal cells may be impacted by the harsh treatment.

Apatone is normally administered in the form of an oral tablet. Injecting Apatone via intravenous infusions introduces the vitamins directly to the bloodstream, preventing potential breakdown in the digestive system and allowing for optimal absorption and bioavailability of the two nutrients. Dosage may vary from patient to patient based on personal health, cancer, and tumor progression, and sensitivity to treatment. Apatone may also be used in conjunction with chemotherapy and other treatments to enhance the effects and support healing once the cancer has been removed.